Robotic Surgery Systems in Massachusetts

Precision Optics Corp. is a vertically integrated optical imaging systems and components manufacturer specializing in micro-precision optics for minimally invasive medical procedures. The company designs, prototypes, and manufactures CMOS endoscopic cameras, micro-optics assemblies (including custom lenses and prisms), fiber bundle scopes, and rod lens systems for endoscopy, 3D visualization, and robotic surgery applications. Their products serve challenging anatomical environments requiring miniaturization down to 0.37 mm lenses and 0.10 mm prisms, addressing applications in gastroenterology, laparoscopy, arthroscopy, and other minimally invasive surgical specialties. Precision Optics offers the Unity™ Imaging Platform, a modular, proven system supporting development from prototyping through production. The company combines opto-mechanical design, optical assembly expertise, and interdisciplinary engineering capabilities to deliver customized solutions meeting specific clinical and manufacturing standards. Beyond medical devices, Precision Optics serves defense and aerospace sectors with micro-optical components. The firm is recognized as a domestic optics manufacturing partner with rapid response capabilities for complex imaging and illumination requirements in confined surgical spaces.

Activ Surgical is a Boston-based digital surgery company specializing in hardware-agnostic surgical software and intraoperative imaging technologies designed to enhance visualization and reduce surgical errors. The company's flagship product, ActivSight™ Intelligent Light, is FDA-cleared and integrates with existing laparoscopic and robotic surgical systems to provide real-time visualization of blood flow and tissue perfusion. ActivSight offers surgeons critical physiological insights invisible to the naked eye through dye-free ActivPerfusion™ and ActivICG™ imaging modes. The patent-protected ActiveEdge™ platform leverages augmented reality, artificial intelligence, and machine learning to improve intraoperative decision-making and address preventable surgical complications. Activ Surgical has achieved significant milestones including the world's first autonomous robotic surgery of soft tissue and CE Mark approval. With $87.5 million in funding, the company operates pilot sites in major U.S. hospital networks, addressing the critical clinical need that preventable surgical errors contribute to over 400,000 deaths annually in the U.S.